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Abstract
Rheumatoid arthritis is an auto-immune disease of the synovial joints, hallmarked by chronic
inflammation and subsequent progressive tissue destruction. TYRO3, AXL and MER (gene
name Mertk) (TAM) receptors are part of a negative feedback signaling system in the
immune reaction and mediate efferocytosis thereby tempering the inflammatory process.
We have shown that Axl-/- and Mertk-/- mice develop more severe arthritis whereas activat-
ing these receptors by overexpressing their ligands Pros1 and Gas6 ameliorates arthritis.
Mice genetically ablated for the three genes of the TAM receptor family Tyro3/Axl/Mertk
(TAM triple knock-out or TKO) have been described to spontaneously develop macroscopic
signs of arthritis. In this study we aimed to analyze arthritis development in TAM TKO mice
histologically to determine the extent and sequence of pathological changes in the joint.
Ankle joints of three different age groups, adolescence (14 weeks), mature adult (34 weeks)
and middle-age (52 weeks), of TAM TKO or wild-type mice were examined macroscopically,
histologically and immunohistochemically. Surprisingly, until the age of 52 weeks, none of
the mice examined developed spontaneous macroscopic signs of arthritis. There was no
synovial inflammation nor any signs of damage to the cartilage or bone. However, bone mar-
row edema was observed in TAM TKO mice in the two latter age groups. The infiltrate in the
bone marrow was characterized by both myeloid cells and lymphocytes. This study showed
that TAM TKO mice developed a pre-stage (pre-clinical phase) of arthritis marked by bone
marrow edema.
Introduction
Rheumatoid arthritis (RA) is an auto-immune disease marked by chronic and unrestrained
inflammation, often in multiple synovial joints in the same patient. In the arthritic joint, the
synovium is infiltrated by both innate and adaptive immune cells which, together with the pro-
liferation of the tissue-resident fibroblasts, leads to pannus tissue formation at the articular car-
tilage and bone interface. Overall, this eventually leads to damage and loss of the articular
cartilage matrix and bone tissue [1, 2].
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One family of receptors that has been linked to RA and experimental models of RA are the
TAM receptors [3–10]. The TAM receptors–TYRO3, AXL and MER (gene name Mertk)–are a
family of tyrosine kinases essential for immune homeostasis by negatively regulating the innate
immune response. Together with their ligands Growth Arrest Specific 6 (GAS6) and Protein S
(PROS1), they also mediate the resolution of inflammation by facilitating efferocytosis [11].
We have found that both AXL and MER play a suppressive role by alleviating joint inflamma-
tion and others have found that TYRO3 plays an enhancing role in bone degradation and
synovial hyperplasia in experimental arthritis [5, 7, 10] (manuscript under review).
More than a decade ago, it was reported that mice lacking all three TAM receptors (triple
knock-out or TKO) develop a lymphoproliferative disorder accompanied by broad-spectrum
autoimmunity including splenomegaly [12]. In this paper, they showed TAM TKO mice spon-
taneously developed clinical characteristics of RA including swollen footpads in a 6-month-
old mouse. Furthermore, deficiency of all three receptors led to enhanced proliferation of both
B cells and T cells. Moreover, auto-antibodies were detectable in serum of these mice.
In this study, we aimed to analyze arthritis development in TAM TKO mice histologically
to determine the extent and sequence of pathological changes in the disease-prone ankle joints.
Surprisingly, until the age of 52 weeks, none of the TAM TKO mice examined developed any
macroscopic signs of arthritis. Histologically, neither tissue destruction nor synovial inflam-
mation was observed. However, bone marrow edema (BME), which was characterized by an
infiltrate of myeloid cells and lymphocytes, was present at the age of 34 weeks which had per-
sisted to the age of 52 weeks.
Materials and methods
Mice
Tyro3/Axl/Mertk-deficient mice were generated as described previously [13]. Mice were bred
and housed in the Salk Institute Animal Facility under a 12 hour light/dark cycle in individu-
ally-ventilated cages, with freely available food and water. Mice were on a mixed C57BL/
6 × 129/Sv background. Both male and female mice were used, and wild-type (WT) and
Tyro3/Axl/Mertk-deficient mice were sex-matched. At the ages of 14 weeks (n = 6), 34 weeks
(n = 6) and 52 weeks (n = 12) (adolescent, mature adult and middle-age, respectively), mice
were sacrificed by an overdose of isoflurane. As the mice were not visibly affected and suffering
by the genotype, no analgesics were used to alleviate suffering. All procedures were approved
by and conducted according to guidelines established by the Salk Institutional Animal Care
and Use Committee (IACUC).
Histology
Whole ankle joints were dissected, fixed in 4% phosphate-buffered formalin, followed by
decalcification with 5% formic acid for 7 days. Tissues were dehydrated with an automated tis-
sue processing apparatus (Leica ASP 300, Leica Biosystems) and embedded in paraffin. Semi-
serial tissue sections (7 μm) were stained with hematoxylin and eosin (H&E) (both Merck),
safranin O and fast green (both Brunschwig Chemie) or were used for immunohistochemical
staining.
Quantification of synovial cellularity and BME
Histological slides of ankle joints stained with H&E were blinded and randomized. For ran-
domization, each joint was given a random number. Pictures of the indicated region of the
ankle joint were taken with the Leica DMR microscope (Leica Microsystems) at 50x
Bone marrow edema in Tyro3/Axl/Mertk-deficient mice
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Fig 1. Effect of genetic deletion of Tyro3/Axl/Mertk on synovial cellularity in ankle joints. (A) Ankle joints of naive wild-type
(WT) and Tyro3/Axl/Mertk triple knock-out (TAM TKO) mice of 14, 34 and 52 weeks old were processed for histology.
Sections were stained with hematoxylin and eosin. Shown are representative pictures in 50x magnification. Staining is
representative for 6 mice (14 and 34 weeks old mice) or 12 mice (52 weeks old mice). (B) Synovial cellularity was quantified in
Bone marrow edema in Tyro3/Axl/Mertk-deficient mice
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magnification. To measure the synovial cellularity, the surface area of the synovium was
selected as the region of interest. The surface area staining positive for H&E was measured and
corrected for the total area that was measured. To measure BME, the surface area of the bone
marrow cavity was selected as the region of interest. The surface area staining positive for
H&E was measured and corrected for the total area (bone marrow cavity) that was measured.
Two to three tissue sections were examined per ankle joint per region (tibia, os talus or os navi-
culare), the average of two to three sections per region was calculated and is depicted. For all
measurements, Leica Application Suite software (Leica Microsystems) was used. WT controls
were set at 1 in Figs 1 and 3. WT controls of different ages were compared in S1 Fig and area
over total area, calculated as percentage, is depicted
Quantification of articular cartilage depletion
Histological slides of ankle joints stained with safranin O and fast green were blinded and ran-
domized. For randomization, each joint was given a random number. Pictures of the indicated
region of the ankle joint were taken with the Leica DMR microscope (Leica Microsystems) at
100x magnification. Two to three tissue sections were examined per ankle joint per region, the
average per joint was calculated and is depicted. To determine cartilage depletion, mean blue
was measured using Leica Application Suite software (Leica Microsystems). The surface area
of the cartilage was selected and the amount of blue light passing through the region of interest
was measured by the software. WT controls were set at 1.
Immunohistochemistry
Protein expression was evaluated on 7 μm tissue sections of ankle joints. Sections were depar-
affinized and rehydrated. Endogenous peroxidase was blocked by 3% (v/v) hydrogen peroxide
in methanol for 20 minutes at room temperature (RT). Sections were washed in between incu-
bation steps with phosphate-buffered saline (PBS) 3 times for 5 minutes. For all sections, a bio-
tin-streptavidin horseradish peroxidase detection system was used according to
manufacturer’s protocol (Vector Laboratories; PK6101). Bound complexes were visualized
with diaminobenzidine (DAB) (Merck) for 10 minutes at RT. Sections were counterstained
with hematoxylin for 30 seconds. Sections were dehydrated and enclosed with Permount.
F4/80. For F4/80 detection, antigen-retrieval was performed in citrate buffer (pH 6.0)
heated to 37ºC for 2 hours and subsequent trypsin treatment (Sigma; T-9201; 0.075% in PBS) at
37˚C for 7 minutes. Sections were blocked by 10% (v/v) rabbit serum in PBS for 20 minutes at
RT. Tissue sections were incubated with rat anti-mouse F4/80 (eBioscience; 14-4801-81; mono-
clonal (BM8); 1 μg/mL) or rat IgG2a (BD Pharmingen; 553927; 1 μg/mL) overnight at 4˚C. Sub-
sequently, sections were incubated with biotinylated rabbit anti-rat IgG (Vector Laboratories;
BA-4001; 1:200) for 30 minutes at RT. Antibodies were diluted in 2% (v/v) rabbit serum in PBS.
CD3. For CD3 detection, antigen retrieval was performed in citrate buffer (pH 6.0) heated
to 60ºC for 10 minutes. Sections were blocked by 5% (w/v) skimmed milk (ELK) 3% (v/v) fetal
calf serum (FCS) 2% (w/v) bovine serum albumin (BSA) in PBS for 1 hour at RT. Tissue sec-
tions were incubated with rabbit anti-mouse CD3 (DAKO; A0452; polyclonal; 3 μg/mL) or
rabbit IgG control (DAKO; X0936; 3 μg/mL) overnight at 4˚C. Subsequently, sections were
incubated with biotinylated goat anti-rabbit IgG (PK6101; 1:400) for 30 minutes at RT. Anti-
bodies were diluted in 5% ELK 3% FCS 2% BSA in PBS.
all joints in a random and blinded manner using Leica Application Suite software. Data are presented as dot-plots with mean.
Data were statistically analyzed with a Mann Whitney test. n = 6 at 14 and 34 weeks old, n = 12 at 52 weeks old. BM = bone
marrow, ON = os naviculare, OT = os talus, S = synovium, T = tibia. Black scale bars represent 100 μm.
https://doi.org/10.1371/journal.pone.0205902.g001
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Fig 2. Effect of genetic deletion of Tyro3/Axl/Mertk on cartilage destruction in ankle joints. (A) Ankle joints of naive wild-type
(WT) and Tyro3/Axl/Mertk triple knock-out (TAM TKO) mice of 14, 34 and 52 weeks old were processed for histology. Sections were
stained with safranin O and fast green. Shown are representative pictures of the tibia–os talus region and os talus–os naviculare region
in 50x magnification. Staining is representative for 6 mice (14 and 34 weeks old mice) or 12 mice (52 weeks old mice). (B) Cartilage
proteoglycan depletion was quantified in both regions in all joints in a random and blinded manner using Leica Application Suite
Bone marrow edema in Tyro3/Axl/Mertk-deficient mice
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CD19. For CD19 detection, antigen retrieval was performed in citrate buffer heated (pH
6.0) to 60ºC for 10 minutes. Sections were blocked by 5% ELK 3% FCS 2% BSA in PBS for 1
hour at RT. Tissue sections were incubated with rabbit anti-mouse CD19 (Abcam; ab203615;
polyclonal; 0.4 μg/mL) or rabbit IgG control (DAKO; X0936; 0.4 μg/mL) overnight at 4˚C.
Subsequently, sections were incubated with biotinylated goat anti-rabbit IgG (PK6101; 1:400)
for 30 minutes at RT. Antibodies were diluted in 5% ELK 3% FCS 2% BSA in PBS.
Statistical analysis
Data were analyzed with GraphPad Prism software (version 5.03). Data are shown as dot-plots
with mean. Analysis of significance was performed using a two-tailed Mann Whitney test. p-
Values lower than 0.05 were considered to be significantly different.
Results
Synovial cellularity and connective tissue integrity is unaltered in the ankle
joints of mice genetically ablated for Tyro3/Axl/Mertk
We examined the ankle joints of mice deficient for Tyro3/Axl/Mertk at three different ages,
namely adolescence (14 weeks), mature adult (34 weeks) and middle-age (52 weeks). Surpris-
ingly, we found that TAM TKO mice up to 1 year of age did not develop any macroscopic
arthritis-like symptoms, such as swollen toes or footpads, spontaneously. The ankle joint is the
privileged site of disease in spontaneous arthritis models [14], but histological examination
showed that the ankle joints in the TAM TKO mice appeared to be indistinguishable from
their WT controls. The synovial cellularity was comparable between TAM TKO and WT mice
at all three ages (Fig 1). Next, we examined the tissue destruction. No bone erosion was
observed in any of the mice. In addition, no cartilage erosion was observed nor were there any
prominent and significant differences on the upper-layer depletion of cartilage proteoglycan
(loss of safranin O staining of the non-calcified upper cartilage layer) (Fig 2).
TAM TKO mice develop BME in the ankle joint region
No tissue destruction nor synovial inflammation was present in any of the joints examined in
TAM TKO mice (Figs 1 and 2). Therefore, we focused on BME, a phenomenon which has
been described to be present in the preclinical phase of RA [15, 16]. It appeared that TAM
TKO mice developed an inflammatory infiltrate in the bone marrow replacing the fat-rich
marrow, termed BME. Indeed, BME was enhanced in TAM TKO mice compared to WT in all
three regions investigated in mature and middle-age mice (Fig 3). During aging, the fat-rich
bone marrow composition in the WT mice was not changed (see S1 Fig). These data show that
the TAM TKO mice examined developed early signs of arthritis without signs of joint pathol-
ogy characteristic for full-blown arthritis.
BME in TAM TKO mice is characterized by cells of myeloid and
lymphocyte lineage
To further characterize the type of cells of the BME, cells were examined morphologically and
cell surface markers were examined by immunohistochemistry. Although to a lesser extent
than in WT mice, adipocytes were still present in the bone marrow of TAM TKO mice (Fig
software. Data are presented as dot-plots with mean. Data were statistically analyzed with a Mann Whitney test. n = 6 at 14 and 34
weeks old, n = 12 at 52 weeks old. ON = os naviculare, OT = os talus, T = tibia. Black scale bars represent 100 μm.
https://doi.org/10.1371/journal.pone.0205902.g002
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Fig 3. Effect of genetic deletion of Tyro3/Axl/Mertk on bone marrow edema. Ankle joints of naive wild-type (WT) and Tyro3/
Axl/Mertk triple knock-out (TAM TKO) mice of 14, 34 and 52 weeks old were processed for histology. (A) Sections were stained
Bone marrow edema in Tyro3/Axl/Mertk-deficient mice
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3A, Fig 4). The infiltrate in the bone marrow of TAM TKO mice consisted of a significant
amount of F4/80+ macrophages (Fig 4A). Moreover, cells of the lymphoid lineage were also
abundantly present. CD20+ B cells, and to a lesser extent, CD3+ T cells were scattered between
the F4/80+ cells (Fig 4B and 4C).
Discussion
In this manuscript, we describe that mice deficient for Tyro3/Axl/Mertk do not develop clinical
characteristics of arthritis until the age of 52 weeks. Nonetheless, they do develop an early phe-
nomenon observed in RA, but which is not specific for RA, namely BME. However, in contrast
to the publication in 2001 [12], they do not (any longer) develop any aberrant macroscopic
signs of arthritis at mature adulthood. Moreover, histologically, joints are not characterized by
synovial inflammation and lymphocyte invasion. This is remarkable as the source of the mice
was from the same laboratory where they were initially described. Nevertheless, we cannot
exclude that TAM TKO mice develop macroscopic signs of arthritis, synovial inflammation or
connective tissue destruction at ages over 52 weeks.
In RA, the fat-rich tissue in the bone marrow, also called the yellow marrow, can be
replaced by a cell-rich inflammatory environment. This phenomenon, called BME, strongly
associates with development of bone erosions and poor functional outcome in patients with
RA [17–21]. Very early in the disease process, BME is present and prognostic for the develop-
ment from undifferentiated arthritis to RA [15, 16, 22]. Moreover, BME is the strongest pre-
dictor for bone erosions in RA patients using magnetic resonance imaging (MRI) [17–21].
Histological and immunohistochemical analysis showed that BME observed by MRI is charac-
terized by an infiltrate of inflammatory cells into the bone marrow normally replaced by adi-
pocytes upon ageing. The infiltrate mainly consists of lymphocytes, CD3+, CD4+, or CD8+ T
cells and CD20+ B cells, but also CD68+ macrophages have been described [23–28]. One study
in TNF-transgenic mice showed that the BME observed in these mice consisted mainly of
myeloid cells [29]. We show that the BME observed in TAM TKO mice is also characterized
by the presence of both lymphocytes and macrophages, the latter being abundantly present as
quantified by the presence of the macrophage marker F4/80. This may confirm the lympho-
proliferative disorder in the TAM TKO mice, caused by constitutively active cells of the mye-
loid lineage, as elegantly demonstrated by adoptive cell transfers [12]. It is unknown whether
the lymphocytes in these mice were targeting any joint-specific antigens that could cause joint-
specific disease.
It is tempting to speculate that the absence of spontaneous arthritis development we
observed compared to the publication of Lu and Lemke [12], is a result of an interaction
between genetic and environmental factors. Phenotypic differences in mice with similar geno-
types, although from a different breeding generation, have been described before [30]. More-
over, long-term breeding of mouse lines results in marked changes in intestinal microbiota
composition and microbiota can account for genotype-specific phenotypes [31]. This is in line
with overall better hygiene and housing facilities of mice compared to a decade ago. Numerous
studies implicate mucosal surfaces as sites of disease initiation in RA [32]. The simultaneous
occurrence of periodontitis, a bacterial-induced inflammation of the gums, and RA suggests
with hematoxylin and eosin. Shown are representative pictures in 100x magnification of the os naviculare, os talus and tibia of 52
weeks old mice. Staining is representative for 12 mice. (B) Bone marrow edema was quantified in all joints in a random and blinded
manner using Leica Application Suite software. Data are presented as dot-plots with mean. Data were statistically analyzed with a
Mann Whitney test. � = p<0.05, �� = p<0.01. n = 6 at 14 and 34 weeks old, n = 12 at 52 weeks old. Black scale bars represent
100 μm. See S1 Fig for comparison of bone marrow edema quantification in WT mice among different ages.
https://doi.org/10.1371/journal.pone.0205902.g003
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Fig 4. Characterization of bone marrow cells in mice lacking Tyro3/Axl/Mertk. Ankle joints of naive wild-type (WT) and Tyro3/Axl/
Mertk triple knock-out (TAM TKO) mice of 52 weeks old were processed for histology. Sections were immunohistochemically stained for
the cell surface marker of interest, or IgG negative control, and counterstained with hematoxylin. Shown are representative pictures in 200x
magnification of the os naviculare, os talus and tibia. Staining is representative for 12 mice. (A) F4/80, (B) CD3, (C) CD19. Black scale bars
represent 100 μm.
https://doi.org/10.1371/journal.pone.0205902.g004
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that oral pathogens may initiate the production of disease-specific antibodies against citrulli-
nated proteins (ACPA) [33]. This coincides with the fact that periodontitis is characterized by
the presence of similar citrullinated auto-antigens in neutrophils, caused by the bacteria Aggre-
gatibacter actinomycetemcomitans, as found in the arthritic joint [34]. Interestingly, the TAM
receptor ligand GAS6 has been shown to be an immunological regulator in oral mucosal
homeostasis [35].
Currently, it remains to be elucidated what causes BME development in TAM TKO mice.
We have shown that MER mediates efferocytosis in the arthritic joint [10]. Moreover, AXL
plays a protective role in experimental arthritis, possibly by regulating the post-translational
activation of IL-1β (manuscript accepted for publication). However, none of the joints exam-
ined in the single knock-out mice for Axl and Mertk showed any signs of BME, nor did the
Axl/Mertk double knock-out (own observations). Therefore, it appears that all 3 receptors
need to be knocked-out in order to develop this phenotype. As we found BME in mature TAM
TKO mice, and this is a phenomenon present in preclinical RA, it is interesting to investigate
whether it would be effective to treat these patients with GAS6 in a preclinical stage to stop the
progression of BME and subsequent bone erosions. To conclude, TAM TKO mice develop
and early stage of RA, namely BME, without spontaneously developing clinical and histopath-
ological signs of arthritis.
Supporting information
S1 Fig. Effect of aging on bone marrow edema. Ankle joints of naive wild-type mice of 14, 34
and 52 weeks old were processed for histology. Sections were stained with hematoxylin and
eosin. Bone marrow edema was quantified in the os naviculare, os talus and tibia in a random
and blinded manner using Leica Application Suite software. Data are presented as dot-plots
with mean. n = 6 at 14 and 34 weeks old, n = 12 at 52 weeks old. See Fig 3 for comparison of
bone marrow edema quantification between wild-type and Tyro3/Axl/Mertk triple knock-out
mice. These data are the same data as in Fig 3 for the wild-type mice, but presented in a differ-
ent manner, to show the effect of aging on bone marrow edema.
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